BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7606857)

  • 1. Development and standardization of solid-phase assays for the detection of antineutrophil cytoplasmic antibodies (ANCA) for clinical application: report of a large clinical evaluation study.
    Hagen EC
    Clin Exp Immunol; 1995 Jul; 101 Suppl 1(Suppl 1):29. PubMed ID: 7606857
    [No Abstract]   [Full Text] [Related]  

  • 2. Development and standardization of solid phase assays for the detection of anti-neutrophil cytoplasmic antibodies (ANCA). A report on the second phase of an international cooperative study on the standardization of ANCA assays.
    Hagen EC; Andrassy K; Csernok E; Daha MR; Gaskin G; Gross WL; Hansen B; Heigl Z; Hermans J; Jayne D; Kallenberg CG; Lesavre P; Lockwood CM; Lüdemann J; Mascart-Lemone F; Mirapeix E; Pusey CD; Rasmussen N; Sinico RA; Tzioufas A; Wieslander J; Wiik A; Van der Woude FJ
    J Immunol Methods; 1996 Sep; 196(1):1-15. PubMed ID: 8841439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rapid-detection GBM-ANCA ELISA. An emergency tool for the early diagnosis of type I and II rapidly progressive glomerulonephritis].
    Arranz O; Ara J; Rodríguez R; Poveda R; Serra A; Solé-Amigó J; Fort J; Mirapeix E; Darnell A
    Nefrologia; 2001; 21(4):349-54. PubMed ID: 11816510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-neutrophil cytoplasmic autoantibodies and patterns of pulmonary disease. A spectrum of pathologic findings.
    Ritter JH
    Am J Clin Pathol; 1995 Jul; 104(1):1-2. PubMed ID: 7611170
    [No Abstract]   [Full Text] [Related]  

  • 5. Atypical autoantigen targets of perinuclear antineutrophil cytoplasm antibodies (P-ANCA): specificity and clinical associations.
    Lesavre P; Noël LH; Gayno S; Nusbaum P; Reumaux D; Erlinger S; Grünfeld JP; Halbwachs-Mecarelli L
    J Autoimmun; 1993 Apr; 6(2):185-95. PubMed ID: 8388691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antineutrophilic cytoplasmic antibodies (ANCA) and vasculitis.
    Staud R; Williams RC
    Compr Ther; 1994; 20(11):623-7. PubMed ID: 7851093
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical evaluation of a capture ELISA for detection of proteinase-3 antineutrophil cytoplasmic antibody.
    Westman KW; Selga D; Bygren P; Segelmark M; Baslund B; Wiik A; Wieslander J
    Kidney Int; 1998 May; 53(5):1230-6. PubMed ID: 9573537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [ANCA vasculitis].
    Bernis C
    Nefrologia; 2003; 23(2):103-6. PubMed ID: 12778872
    [No Abstract]   [Full Text] [Related]  

  • 9. Diversity of antigens recognized by ANCA--is this of clinical relevance?
    Kallenberg CG
    Nephrol Dial Transplant; 1994; 9(3):228-9. PubMed ID: 8052425
    [No Abstract]   [Full Text] [Related]  

  • 10. [Neutrophil anticytoplasmic antibodies: their diagnostic utility in vasculitis and glomerulonephritis].
    Bosch X; Mirapeix E; Font J; López-Soto A; Rodríguez R; Vivancos J; Revert L; Ingelmo M; Urbano-Márquez A
    Med Clin (Barc); 1994 Mar; 102(11):412-7. PubMed ID: 8182997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and specificity of p-ANCA in rheumatic diseases.
    Braun MG; Csernok E; Schmitt WH; Gross WL
    Adv Exp Med Biol; 1993; 336():371-3. PubMed ID: 8296638
    [No Abstract]   [Full Text] [Related]  

  • 12. Audit of the clinical usefulness of a rapid qualitative ELISA screen for antimyeloperoxidase and antiproteinase 3 antibodies in the assessment of patients with suspected vasculitis.
    Aslam A; Newman TL; Misbah SA
    J Clin Pathol; 2003 Oct; 56(10):775-7. PubMed ID: 14514783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-neutrophil cytoplasmic antibodies in 566 European patients with systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies. European Concerted Action on the Immunogenetics of SLE.
    Galeazzi M; Morozzi G; Sebastiani GD; Bellisai F; Marcolongo R; Cervera R; De Ramòn Garrido E; Fernandez-Nebro A; Houssiau F; Jedryka-Goral A; Mathieu A; Papasteriades C; Piette JC; Scorza R; Smolen J
    Clin Exp Rheumatol; 1998; 16(5):541-6. PubMed ID: 9779300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical interpretation of antineutrophil cytoplasmic antibodies: parvovirus B19 infection as a pitfall.
    Hermann J; Demel U; Stünzner D; Daghofer E; Tilz G; Graninger W
    Ann Rheum Dis; 2005 Apr; 64(4):641-3. PubMed ID: 15485998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection rate and antigenic specificities of antineutrophil cytoplasmic antibodies in chinese patients with clinically suspected vasculitis.
    Xin G; Zhao MH; Wang HY
    Clin Diagn Lab Immunol; 2004 May; 11(3):559-62. PubMed ID: 15138182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Usefulness of anti-neutrophil cytoplasmic antibodies, anti-proteinase 3 and anti-myeloperoxidase in management of small vessel vasculitis].
    Ara J; Mirapeix E; Rodríguez R; Pascual J; Alvarez L; Darnell A
    Med Clin (Barc); 1998 Oct; 111(14):536-8. PubMed ID: 9859079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides.
    Bonaci-Nikolic B; Nikolic MM; Andrejevic S; Zoric S; Bukilica M
    Arthritis Res Ther; 2005; 7(5):R1072-81. PubMed ID: 16207324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel capture-ELISA for detection of anti-neutrophil cytoplasmic antibodies (ANCA) based on c-myc peptide recognition in carboxy-terminally tagged recombinant neutrophil serine proteases.
    Lee AS; Finkielman JD; Peikert T; Hummel AM; Viss MA; Specks U
    J Immunol Methods; 2005 Dec; 307(1-2):62-72. PubMed ID: 16242707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of capture ELISA for detection of antineutrophil cytoplasmic antibodies directed against proteinase 3 in Wegener's granulomatosis: first results from a multicentre study.
    Csernok E; Holle J; Hellmich B; Willem J; Tervaert C; Kallenberg CG; Limburg PC; Niles J; Pan G; Specks U; Westman K; Wieslander J; De Groot K; Gross WL
    Rheumatology (Oxford); 2004 Feb; 43(2):174-80. PubMed ID: 14585921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variations in performance characteristics of commercial enzyme immunoassay kits for detection of antineutrophil cytoplasmic antibodies: what is the optimal cut off?
    Holle JU; Hellmich B; Backes M; Gross WL; Csernok E
    Ann Rheum Dis; 2005 Dec; 64(12):1773-9. PubMed ID: 15843447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.